Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity, Vaccine”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00748813
What this trial is testing

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

Who this might be right for
Seasonal Influenza
Novartis Vaccines 133
Early research (Phase 1)Study completedNCT01302990
What this trial is testing

Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults

Who this might be right for
Flu
Medicago 100
Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Early research (Phase 1)Study completedNCT00376090
What this trial is testing

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 48
Early research (Phase 1)Study completedNCT01829490
What this trial is testing

Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults

Who this might be right for
Tuberculosis
University of Oxford 42
Testing effectiveness (Phase 2)Ended earlyNCT03531710
What this trial is testing

An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311

Who this might be right for
Alzheimer's Disease
United Neuroscience Ltd. 34
Large-scale testing (Phase 3)Study completedNCT00761631
What this trial is testing

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years

Who this might be right for
Healthy Subjects
Pfizer 1,200
Early research (Phase 1)Study completedNCT00001041
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT07095231
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00001445
What this trial is testing

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 32
Large-scale testing (Phase 3)WithdrawnNCT05166031
What this trial is testing

Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine

Who this might be right for
Poliomyelitis
Fidec Corporation
Early research (Phase 1)Study completedNCT00001053
What this trial is testing

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT03929172
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Who this might be right for
Papillomavirus Infections
2A Pharma AB 20
Very early researchStudy completedNCT03277456
What this trial is testing

Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1

Who this might be right for
Human Volunteers
Barinthus Biotherapeutics 6
Testing effectiveness (Phase 2)Study completedNCT00689351
What this trial is testing

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea

Who this might be right for
Pneumococcal Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer 180
Testing effectiveness (Phase 2)UnknownNCT05329051
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Sinocelltech Ltd. 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07675629
What this trial is testing

Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults

Who this might be right for
HIV Prevention
Worcester HIV Vaccine 126
Testing effectiveness (Phase 2)Study completedNCT00857493
What this trial is testing

Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

Who this might be right for
Smallpox
Bavarian Nordic 120
Testing effectiveness (Phase 2)Study completedNCT03203421
What this trial is testing

A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2

Who this might be right for
Malaria
University of Oxford 18
Post-approval studies (Phase 4)Study completedNCT02563093
What this trial is testing

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 208
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation